Cart
×
In this webinar, Sarepta Therapeutics presents an update on their Duchenne muscular dystrophy pipeline. Diane Berry, PhD, Senior Vice President, Global Health Policy, Government and Patient Affairs and Louise Rodino-Klapac, PhD, Senior Vice President, Gene Therapy speak on the webinar. The webinar provides an overview of Sarepta’s scientific research platforms, active clinical trial programs and information about educational resources.
Recorded: Jun 11, 2020 04:00 PM in Eastern Time (US and Canada)